Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11590205
APP PUB NO 20180271948A1
SERIAL NO

15763050

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Certain embodiments are directed to a formulation of a therapeutic agent, as well as a method of making such a formulation, comprising at least one therapeutic agent dissolved in an aprotic polar solvent system comprising at least one ionization stabilizing excipient in a concentration sufficient to impart physical and chemical stability to the therapeutic agent.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
XERIS PHARMACEUTICALS INC1375 WEST FULTON STREET SUITE 1300 CHICAGO IL 60607

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Donovan, Martin Chicago, US 28 67
Prestrelski, Steven Chicago, US 30 353
Sandoval, Michael Chicago, US 35 1406

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Aug 28, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 28, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 28, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00